Revvity Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Revvity Inc. (RVTY) shares rose 1.19% to $116.02 on Monday, marking its second consecutive day of gains despite a broader market decline. However, the stock underperformed relative to competitors like Danaher, IDEXX Laboratories, and Agilent Technologies, which posted higher percentage increases. Revvity closed near its 52-week high of $118.30, with trading volume remaining below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Revvity Inc. (RVTY) rallied 1.19% to $116.02 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.
This was the stock's second consecutive day of gains.
Revvity Inc. closed 1.93% short of its 52-week high of $118.30, which the company achieved on January 22nd.
The stock underperformed when compared to some of its competitors Monday, as Danaher Corp. (DHR) rose 2.25% to $209.37, IDEXX Laboratories Inc. (IDXX) rose 1.55% to $595.76, and Agilent Technologies Inc. (A) rose 1.88% to $148.72.
Trading volume (1.3 M) remained 301,209 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-10-26 1716ET
